Literature DB >> 27404266

Pancreatic neuroendocrine tumors: contemporary diagnosis and management.

Sheeva K Parbhu1, Douglas G Adler1.   

Abstract

Pancreatic neuroendocrine tumors (PNETs) are neoplasms that arise from the hormone producing cells of the islets of Langerhans, also known as pancreatic islet cells. PNETs are considered a subgroup of neuroendocrine tumors, and have unique biology, natural history and clinical management. These tumors are classified as 'functional' or 'non-functional' depending on whether they release peptide hormones that produce specific hormone- related symptoms, usually in established patterns based on tumor subtype. This manuscript will review pancreatic neuroendocrine tumor subtypes, syndromes, diagnosis, and clinical management.

Entities:  

Keywords:  Pancreatic neuroendocrine tumors; VIPoma; gastrinoma; glucagonoma; insulinoma; somatostatinoma

Mesh:

Substances:

Year:  2016        PMID: 27404266     DOI: 10.1080/21548331.2016.1210474

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  12 in total

1.  A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Authors:  Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Jeffrey M Switchenko; Joseph Lipscomb; Valentina Andreasi; Stefano Partelli; Adriana C Gamboa; Rachel M Lee; George A Poultsides; Mary Dillhoff; Flavio G Rocha; Kamran Idrees; Clifford S Cho; Sharon M Weber; Ryan C Fields; Charles A Staley; Massimo Falconi; Shishir K Maithel
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

2.  Radiomics Analysis Based on Diffusion Kurtosis Imaging and T2 Weighted Imaging for Differentiation of Pancreatic Neuroendocrine Tumors From Solid Pseudopapillary Tumors.

Authors:  Yan-Jie Shi; Hai-Tao Zhu; Yu-Liang Liu; Yi-Yuan Wei; Xiu-Bo Qin; Xiao-Yan Zhang; Xiao-Ting Li; Ying-Shi Sun
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 6.244

3.  Clinicopathological Data and Treatment Modalities for Pancreatic Somatostatinomas.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Eleni Papoutsi; Vasiliki Ntella; Prodromos Kanavidis; Athanasios Sioulas; Marina Tsoli; Georgios Charalampopoulos; Michail Vailas; Evangelos Felekouras
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 4.  Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review.

Authors:  Qun Chen; Wu-Jun Wang; Yun-Xuan Jia; Hao Yuan; Peng-Fei Wu; Wan-Li Ge; Ling-Dong Meng; Xu-Min Huang; Peng Shen; Tao-Yue Yang; Yi Miao; Jing-Jing Zhang; Kui-Rong Jiang
Journal:  Cell Biosci       Date:  2021-05-13       Impact factor: 7.133

Review 5.  When should genetic testing be performed in patients with neuroendocrine tumours?

Authors:  Triona O'Shea; Maralyn Druce
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

6.  Malignant pancreatic tumor other than solid pseudopapillary tumor in pediatric patients: A single-center experience.

Authors:  Duon Kim; Hee-Beom Yang; Hyun-Young Kim
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

7.  18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor.

Authors:  Marcello Moro Queiroz; Carlos Diego Holanda Lopes; Alessandra Corte Real Salgues; Felipe de Galiza Barbosa; Emerson Shigueaki Abe; Thales Parenti Silveira; Marcel Cerqueira Cesar Machado; Fernanda Cunha Capareli
Journal:  Eur J Hybrid Imaging       Date:  2021-05-10

8.  Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Dina Alani; Samah Chahed; Dallas Donohoe; Brynn Voy; Jay Whelan; Ahmed Bettaieb
Journal:  Cell Commun Signal       Date:  2020-08-14       Impact factor: 5.712

9.  A Unique Presentation and Clinical Course of a Pancreatic Vasoactive Intestinal Polypeptide Secreting Tumor in a 68-year-old Male.

Authors:  Balaji R Jagdish; William R Kilgore
Journal:  Kans J Med       Date:  2020-10-20

10.  Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors.

Authors:  Sergio Pedraza-Arevalo; Alejandro Ibáñez-Costa; Ricardo Blázquez-Encinas; Miguel R Branco; Mari C Vázquez-Borrego; Aura D Herrera-Martínez; Eva Venegas-Moreno; Raquel Serrano-Blanch; Álvaro Arjona-Sánchez; María A Gálvez-Moreno; Marta Korbonits; Alfonso Soto-Moreno; Manuel D Gahete; Marika Charalambous; Raúl M Luque; Justo P Castaño
Journal:  Mol Oncol       Date:  2021-10-26       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.